Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Key result
A KDIGO review highlights that valvular heart disease in chronic kidney disease patients has distinct pathophysiology and higher risks, summarizing knowledge gaps and research priorities.
Why the study?
CKD is a major risk factor for VHD, but general population knowledge is not always applicable due to different pathophysiology, high comorbidity, and elevated periprocedural risks.
Design
Review and controversies conference report
Authors
Discussion
Loading...
Member takes
Implication
CKD patients face elevated VHD risk and mortality; review leaves open evidence-based valve management strategies in this population.
Structured PICO
P
Population
Patients with chronic kidney disease (CKD) and valvular heart disease (VHD)
This KDIGO review highlights the unique pathophysiology and elevated risks of valvular heart disease in patients with chronic kidney disease, emphasizing the need for tailored research and management strategies.
Cite This Study
Marwick et al. (2019) conducted a review in Chronic kidney disease and valvular heart disease. A KDIGO review highlights that valvular heart disease in chronic kidney disease patients has distinct pathophysiology and higher risks, summarizing knowledge gaps and research priorities.